BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
0.7850
+0.0124 (1.60%)
At close: Nov 20, 2026, 4:00 PM EST
0.7500
-0.0350 (-4.46%)
After-hours: Nov 20, 2026, 5:05 PM EST
BioCardia Market Cap
BioCardia has a market cap or net worth of $11.88 million as of November 20, 2026. It is the 39,985th most valuable company in the world and the 5,363rd biggest in the United States. Its market cap has decreased by 15.11% in one year.
Market Cap
11.88M
Enterprise Value
10.22M
1-Year Change
-15.11%
Global Rank
Country Rank
#5,363 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, BioCardia's market cap has increased from $6.70M to $11.88M, an increase of 77.37%. That is a compound annual growth rate of 2.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 11.88M | -10.65% |
| Dec 31, 2025 | 13.30M | 33.00% |
| Dec 31, 2024 | 10.00M | -30.56% |
| Dec 29, 2023 | 14.40M | -61.39% |
| Dec 30, 2022 | 37.30M | 14.07% |
| Dec 31, 2021 | 32.70M | -23.95% |
| Dec 31, 2020 | 43.00M | 71.31% |
| Dec 31, 2019 | 25.10M | -42.69% |
| Dec 31, 2018 | 43.80M | -51.22% |
| Dec 29, 2017 | 89.80M | -63.96% |
| Dec 30, 2016 | 249.20M | 1,254.35% |
| Dec 31, 2015 | 18.40M | -27.27% |
| Dec 31, 2014 | 25.30M | 37.50% |
| Dec 31, 2013 | 18.40M | 33.33% |
| Dec 31, 2012 | 13.80M | -14.29% |
| Dec 30, 2011 | 16.10M | 40.00% |
| Dec 31, 2010 | 11.50M | -93.63% |
| Dec 31, 2009 | 180.60M | -38.76% |
| Dec 31, 2008 | 294.90M | 1,614.53% |
| Dec 31, 2007 | 17.20M | 2,357.14% |
| Dec 29, 2006 | 700.00K | -22.22% |
| Dec 30, 2005 | 900.00K | 12.50% |
| Dec 31, 2004 | 800.00K | -72.41% |
| Dec 31, 2003 | 2.90M | 262.50% |
| Dec 31, 2002 | 800.00K | -73.33% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Akari Therapeutics, | 13.03M |
| Fractyl Health | 12.81M |
| aTyr Pharma | 12.72M |
| Neuphoria Therapeutics | 12.28M |
| Pluri | 12.10M |
| Chemomab Therapeutics | 11.88M |
| Dyadic International | 11.51M |
| Jasper Therapeutics | 11.47M |